Skip to content

A comparative study to assess the effect of intense pulsed light therapy with topical 2.5% benzoyl peroxide versus topical 2.5% benzoyl peroxide alone in acne patients

A COMPARATIVE STUDY TO ASSESS THE EFFICACY AND SAFETY OF INTENSE-PULSED LIGHT THERAPY WITH TOPICAL BENZOYL PEROXIDE 2.5% VERSUS BENZOYL PEROXIDE 2.5% ALONE IN MILD TO MODERATE ACNE VULGARIS

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044041
Enrollment
60
Registered
2022-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Intense pulsed light therapy with topical Benzoyl Peroxide 2.5%: 2.5% topical benzoyl peroxide daily at night(except on IPL days) with intense pulse light therapy once in a month (410nm

Sponsors

R Aishwarya Meenaloshini
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: �Patients of both genders above 18 years & below 30 years with acne vulgaris. �Not receiving any systemic or topical acne treatment for last 2 weeks. �No tendency to develop keloid or hypertrophic scar. �Not receiving topical and systemic steroids for last 6 months. �Patients willing to give a written informed consent

Exclusion criteria

Exclusion criteria: Before starting the study �Pregnant and lactating women. �Women planning for pregnancy �Patients with co-morbidities-DM,SHT,TB,CAD,EPILEPSY,BA,HIV During Study �If patient develops severe side effects during the treatment �If patient wants alternate treatment during the study. �If patient wants to discontinue the treatment

Design outcomes

Primary

MeasureTime frame
The end point will be the evaluation of clinical response to both the mode of treatment at 16 weeks after treatment initiation. Responses in between the study will be noticed & recorded using Comprehensive Acne Severity Scale(CASS) and patient satisfaction scoreTimepoint: 16 weeks

Secondary

MeasureTime frame
To look for reduction of post acne pigmentation following treatment and recurrenceTimepoint: 8 weeks

Countries

India

Contacts

Public ContactDr R Aishwarya Meenaloshini

Chengalpattu Medical College

fathima_smc@yahoo.co.in9791332825

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026